Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo

Medicine and Dentistry

• Cancer Cell 100%
• In Vitro 100%
• Evaluation Study 100%
• Combination Therapy 100%
• Pancreas Cancer 100%
• Vitamin D Analogue 100%
• Calcitriol 66%
• Hypercalcaemia 66%
• Cells 33%
• Therapeutic Procedure 33%
• Surgery 33%
• Cell Proliferation 33%
• Body Weight 33%
• Upregulation 33%
• Disease 33%
• Patient 33%
• down Regulation 33%
• Clinical Trial 33%
• Programmed Cell Death 33%
• Tumor Progression 33%
• Cancer Growth 33%
• Xenograft 33%
• Carcinoma Cell 33%
• Radiation Therapy 33%
• Weight Loss 33%
• Chemotherapy 33%
• G1 Phase 33%
• Cyclin D3 33%
• Pancreas Carcinoma 33%
• Cyclin-Dependent Kinase 4 33%
• Cyclin Dependent Kinase Inhibitor 1A 33%
• Cyclin-Dependent Kinase 5 33%
• Protein Tyrosine Phosphatase 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Pancreas Cancer 100%
• Calcitriol 66%
• Hypercalcemia 66%
• Diseases 33%
• Cell Proliferation 33%
• Malignant Neoplasm 33%
• Apoptosis 33%
• Mouse Model 33%
• Tumor Growth 33%
• Cancer Growth 33%
• Cyclin Dependent Kinase 4 33%
• Protein Tyrosine Phosphatase 33%
• Cyclin D3 33%
• Cyclin Dependent Kinase Inhibitor 1A 33%
• Cyclin Dependent Kinase Inhibitor 1B 33%
• Cyclin Dependent Kinase 5 33%
• Pancreas Carcinoma 33%